Published in J Vac Sci Technol B Nanotechnol Microelectron on March 23, 2012
Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano (2013) 0.94
Synthesis and surface functionalization of silica nanoparticles for nanomedicine. Surf Sci Rep (2014) 0.88
Evolution of contrast agents for ultrasound imaging and ultrasound-mediated drug delivery. Front Pharmacol (2015) 0.85
Sol-gel synthesis and electrospraying of biodegradable (P2O5)55-(CaO)30-(Na2O)15 glass nanospheres as a transient contrast agent for ultrasound stem cell imaging. ACS Nano (2015) 0.81
Hollow iron-silica nanoshells for enhanced high intensity focused ultrasound. J Surg Res (2014) 0.81
Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery. Annu Rev Biomed Eng (2007) 5.82
Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3. Circulation (2003) 3.15
RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther (2005) 2.68
Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol (2009) 2.27
Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals. Small (2010) 2.10
Contrast-agent detection and quantification. Eur Radiol (2004) 1.77
Ultrasound contrast agents: an overview. Eur J Radiol (2006) 1.76
Dynamic contrast-enhanced ultrasonography (DCE-US) with quantification of tumor perfusion: a new diagnostic tool to evaluate the early effects of antiangiogenic treatment. Eur Radiol (2007) 1.38
Injectable sustained release microparticles of curcumin: a new concept for cancer chemoprevention. Cancer Res (2010) 1.32
Evaluation of tumor angiogenesis with US: imaging, Doppler, and contrast agents. Acad Radiol (2000) 1.28
Hard shell gas-filled contrast enhancement particles for colour Doppler ultrasound imaging of tumors. Medchemcomm (2010) 1.11
Mutual information-based multimodal image registration using a novel joint histogram estimation. Comput Med Imaging Graph (2008) 1.10
Contrast-enhanced sonography helps in discrimination of benign from malignant adnexal masses. J Ultrasound Med (2004) 1.03
Contrast-enhanced ultrasound for diagnosis of prostate cancer and kidney lesions. Eur J Radiol (2007) 0.93
Potential impact and utilization of ultrasound contrast media. Eur Radiol (2004) 0.92
Quantitative contrast enhanced ultrasound and CT assessment of tumor response to antiangiogenic therapy in rats. Ultrasound Med Biol (2007) 0.91
Hollow spherical nanoparticulate aggregates as potential ultrasound contrast agent: shell thickness characterization. Drug Dev Ind Pharm (2009) 0.90
Contrast-enhanced ultrasound for detection and diagnosis of renal clear cell carcinoma. Chin Med J (Engl) (2009) 0.86
Respiratory motion correction in free-breathing ultrasound image sequence for quantification of hepatic perfusion. Med Phys (2011) 0.86
Quantitative evaluation of viable tissue perfusion changes with contrast-enhanced greyscale ultrasound in a mouse hepatoma model following treatment with different doses of thalidomide. Br J Radiol (2011) 0.85
Ultrasound contrast agents. Clin Radiol (1994) 0.82
Tissue-penetrating delivery of compounds and nanoparticles into tumors. Cancer Cell (2009) 4.02
Smad3 mediates transforming growth factor-beta-induced alpha-smooth muscle actin expression. Am J Respir Cell Mol Biol (2003) 2.69
Accuracy of ultrasonography and magnetic resonance imaging in the diagnosis of placenta accreta. Obstet Gynecol (2006) 2.50
Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) in the liver - update 2012: A WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound Med Biol (2012) 2.39
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proc Natl Acad Sci U S A (2011) 1.68
Breast cancer version 3.2014. J Natl Compr Canc Netw (2014) 1.63
Breast Cancer Version 2.2015. J Natl Compr Canc Netw (2015) 1.59
Comparative healing of human cutaneous surgical incisions created by the PEAK PlasmaBlade, conventional electrosurgery, and a standard scalpel. Plast Reconstr Surg (2011) 1.55
Flowering time control: another window to the connection between antisense RNA and chromatin. Trends Genet (2012) 1.42
Invasive Breast Cancer Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.40
Gut-enriched Krüppel-like factor interaction with Smad3 inhibits myofibroblast differentiation. Am J Respir Cell Mol Biol (2006) 1.38
Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis. Cancer Res (2010) 1.34
Nanoparticle-induced vascular blockade in human prostate cancer. Blood (2010) 1.30
Essential role of MeCP2 in the regulation of myofibroblast differentiation during pulmonary fibrosis. Am J Pathol (2011) 1.22
A gene loop containing the floral repressor FLC is disrupted in the early phase of vernalization. EMBO J (2012) 1.17
Epigenetic regulation of myofibroblast differentiation by DNA methylation. Am J Pathol (2010) 1.16
CCAAT/enhancer-binding protein beta isoforms and the regulation of alpha-smooth muscle actin gene expression by IL-1 beta. J Immunol (2004) 1.16
Congruence of imaging estimators and mechanical measurements of viscoelastic properties of soft tissues. Ultrasound Med Biol (2007) 1.12
Cisterna chyli at routine abdominal MR imaging: a normal anatomic structure in the retrocrural space. Radiographics (2004) 1.11
Hard shell gas-filled contrast enhancement particles for colour Doppler ultrasound imaging of tumors. Medchemcomm (2010) 1.11
Selective detection of vapor phase hydrogen peroxide with phthalocyanine chemiresistors. J Am Chem Soc (2008) 1.07
Hollow silica and silica-boron nano/microparticles for contrast-enhanced ultrasound to detect small tumors. Biomaterials (2012) 1.06
Comparative gas sensing in cobalt, nickel, copper, zinc, and metal-free phthalocyanine chemiresistors. J Am Chem Soc (2009) 1.06
Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results. Urology (2004) 1.05
Gadolinium-DTPA-dextran: a macromolecular MR blood pool contrast agent. Acad Radiol (2004) 1.05
Shear wave speed recovery using moving interference patterns obtained in sonoelastography experiments. J Acoust Soc Am (2007) 1.03
Giant peritoneal loose bodies. J Gastrointest Surg (2006) 1.03
Contrast-enhanced ultrasound as a predictor of treatment efficacy within 2 weeks after transarterial chemoembolization of hepatocellular carcinoma. J Vasc Interv Radiol (2007) 1.02
Angiogenesis: noninvasive quantitative assessment with contrast-enhanced functional US in murine model. Radiology (2006) 1.02
Mechanism of parenchymal enhancement of the liver with a microbubble-based US contrast medium: an intravital microscopy study in rats. Radiology (2002) 1.01
Three-dimensional registration of prostate images from histology and ultrasound. Ultrasound Med Biol (2004) 1.00
Detection of nitroaromatic explosives based on photoluminescent polymers containing metalloles. J Am Chem Soc (2003) 0.99
Oncologic safety of skin-sparing and nipple-sparing mastectomy: a discussion and review of the literature. Int J Surg Oncol (2012) 0.98
Multimodality diagnosis of liver tumors: feature analysis with CT, liver-specific and contrast-enhanced MR, and a computer model. Acad Radiol (2002) 0.98
Senior adult oncology, version 2.2014: clinical practice guidelines in oncology . J Natl Compr Canc Netw (2014) 0.97
Prostate cancer: three-dimensional sonoelastography for in vitro detection. Radiology (2005) 0.96
Malignant phyllodes tumors: a review of 752 cases. Am Surg (2007) 0.96
Enzyme-directed assembly of a nanoparticle probe in tumor tissue. Adv Mater (2013) 0.95
Aptamer-crosslinked microbubbles: smart contrast agents for thrombin-activated ultrasound imaging. Adv Mater (2012) 0.95
Phospholipid/Carbocyanine Dye-Shelled Microbubbles as Ultrasound-Modulated Fluorescent Contrast Agents. Soft Matter (2013) 0.95
Use of microfluidics chips for the detection of human telomerase RNA. Anal Biochem (2003) 0.95
Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry. Nucl Med Biol (2005) 0.94
PI3Kα activates integrin α4β1 to establish a metastatic niche in lymph nodes. Proc Natl Acad Sci U S A (2013) 0.94
Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles. PLoS One (2013) 0.94
Color Doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron-silica nanoshells. ACS Nano (2013) 0.94
Enzyme-directed assembly of nanoparticles in tumors monitored by in vivo whole animal imaging and ex vivo super-resolution fluorescence imaging. J Am Chem Soc (2013) 0.93
A preliminary report on the clinical experience with AlloDerm in breast reconstruction and its radiologic appearance. Am Surg (2010) 0.92
Validation of ultrasound contrast destruction imaging for flow quantification. Ultrasound Med Biol (2003) 0.92
Characterization of individual ultrasound microbubble dynamics with a light-scattering system. J Biomed Opt (2011) 0.91
Neural progenitor cells labeling with microbubble contrast agent for ultrasound imaging in vivo. Biomaterials (2013) 0.91
Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy. Ann Surg Oncol (2014) 0.90
Adenoid cystic breast carcinoma: is axillary staging necessary in all cases? Results from the California Cancer Registry. Breast J (2011) 0.90
Effect of lipoxin A4 on myocardial ischemia reperfusion injury following cardiac arrest in a rabbit model. Inflammation (2013) 0.90
Gas sensing mechanism in chemiresistive cobalt and metal-free phthalocyanine thin films. J Am Chem Soc (2007) 0.90
Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis. Am J Pathol (2012) 0.89
Angiogenesis model for ultrasound contrast research: exploratory study. Acad Radiol (2004) 0.88
Facile One-Pot Synthesis of Polymer-Phospholipid Composite Microbubbles with Enhanced Drug Loading Capacity for Ultrasound-Triggered Therapy. Soft Matter (2011) 0.88
Red-luminescent europium (III) doped silica nanoshells: synthesis, characterization, and their interaction with HeLa cells. J Biomed Opt (2011) 0.88
Efficient Exploration of Membrane-Associated Phenomena at Atomic Resolution. J Membr Biol (2015) 0.87
Dual-porosity hollow nanoparticles for the immunoprotection and delivery of nonhuman enzymes. Nano Lett (2014) 0.87
Lung bone marrow-derived hematopoietic progenitor cells enhance pulmonary fibrosis. Am J Respir Crit Care Med (2013) 0.87
The effect of simvastatin on mRNA expression of transforming growth factor-beta1, bone morphogenetic protein-2 and vascular endothelial growth factor in tooth extraction socket. Int J Oral Sci (2009) 0.87
Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1. Am J Pathol (2013) 0.86
A molecular CT blood pool contrast agent. Acad Radiol (2002) 0.86
Intraoperative ultrasound using phase inversion harmonic imaging: first experiences. Neurosurgery (2007) 0.86
Computerized decision support system for intraoperative analysis of margin status in breast conservation therapy. ISRN Surg (2012) 0.85
Transcranial ultrasound angiography (T USA): a new approach for contrast specific imaging of intracranial arteries. Ultrasound Med Biol (2005) 0.85
Time course and role of morphine dose and concentration in intrathecal granuloma formation in dogs: a combined magnetic resonance imaging and histopathology investigation. Anesthesiology (2006) 0.84
Proteome analysis of up-regulated proteins in the rat spinal cord induced by transection injury. Proteomics (2006) 0.84
Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis. J Pathol (2013) 0.84
Toward in vivo detection of hydrogen peroxide with ultrasound molecular imaging. Biomaterials (2013) 0.83
Gastrodin ameliorates Parkinson's disease by downregulating connexin 43. Mol Med Rep (2013) 0.83
Iron(III)-doped, silica nanoshells: a biodegradable form of silica. J Am Chem Soc (2012) 0.83
The effect of inhaled gases on ultrasound contrast agent longevity in vivo. Mol Imaging Biol (2012) 0.83
Carotid arteries: contrast-enhanced US angiography--preliminary clinical experience. Radiology (2003) 0.83
A general process for the development of peptide-based immunoassays for monoclonal antibodies. Cancer Chemother Pharmacol (2010) 0.83
In vivo ultrasound visualization of non-occlusive blood clots with thrombin-sensitive contrast agents. Biomaterials (2013) 0.82